<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is characterized by <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT) and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> with respect to <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism but not amino acid metabolism </plain></SENT>
<SENT sid="1" pm="."><plain>We examined whether whole-body leucine and protein metabolism are dysregulated in HIV-infected individuals with IGT </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="105" ids="17234">Glucose</z:chebi> and leucine kinetics were measured under fasting insulin conditions and during euglycemic <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> using primed-constant infusions of <z:chebi fb="0" ids="29294">2H2</z:chebi>-<z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="18" ids="36928">13C</z:chebi>-leucine in 10 HIV-seronegative control subjects, 16 HIV+ subjects with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance, and 21 HIV+IGT subjects </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="105" ids="17234">Glucose</z:chebi> disposal rate during <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> was lower in HIV+IGT than the other two groups </plain></SENT>
<SENT sid="4" pm="."><plain>Absolute plasma leucine levels and rate of appearance (whole-body proteolysis) were higher in HIV+IGT at <z:hpo ids='HP_0000001'>all</z:hpo> insulin levels but declined in response to <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> in parallel to those in the other two groups </plain></SENT>
<SENT sid="5" pm="."><plain>HIV+IGT had greater visceral <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e>, fasting serum interleukin (IL)-8 and free fatty acid levels, and higher <z:chebi fb="23" ids="18059">lipid</z:chebi> oxidation rates during the clamp than the other two groups </plain></SENT>
<SENT sid="6" pm="."><plain>These findings implicate several factors in the insulin signaling pathway, which may be further dysregulated in HIV+IGT, and support the notion that insulin signaling pathways for <z:chebi fb="105" ids="17234">glucose</z:chebi> and leucine metabolism may be disrupted by increased proinflammatory adipocytokines (IL-8) and increased <z:chebi fb="23" ids="18059">lipid</z:chebi> oxidation </plain></SENT>
<SENT sid="7" pm="."><plain>Increased proteolysis may provide amino acids for gluconeogenesis, exacerbating <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> in HIV </plain></SENT>
</text></document>